Wow, we are in free fall, buying opportunity or am I a fool not to sell ?????? I thought the resource report was what was expected, why such negative sentiment?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
